Metraipolis › archive › dc_5dfcf7527a16
Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42222162
- DOI
- 10.3389/fphar.2026.1831031
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T16:27:44.044Z
- SHA-256 of the archived text
193d97f7b9b84b7352dc3ce3c220a0da3c9bd407f2ebc99f493b1f9bedc62419- Stable URL of this page
https://metraipolis.com/documento/dc_5dfcf7527a16
How to cite
Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162 — Europe PMC (en), https://europepmc.org/article/MED/42222162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5dfcf7527a16 (Metraipolis archive dc_5dfcf7527a16, sha256 193d97f7b9b84b7352dc3ce3c220a0da3c9bd407f2ebc99f493b1f9bedc62419)
BibTeX
@misc{dc5dfcf7527a16,
title = {Mechanisms of salvianolic acids in kidney disease therapy: advances and perspectives — Europe PMC PMID:42222162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42222162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5dfcf7527a16; sha256 193d97f7b9b84b7352dc3ce3c220a0da3c9bd407f2ebc99f493b1f9bedc62419},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222162. Agents can read the archived copy with the MCP tool read_document.